Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)

NCT06999902 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.

NCT NCT06999902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06999902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)
Lead sponsor
Praxis Precision Medicines
Phase
Phase 2/3
Overall status
Completed
Start date
December 11, 2024
Completion date
May 14, 2026
Enrollment
255 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

focal seizure